ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,437, issued on Dec. 23, was assigned to GenVivo Inc. (San Marino, Calif.).
"Compositions and methods for therapeutic delivery" was invented by Makoto Sato (Pasadena, Calif.), Alexander T. Cunha (Los Angeles), Cecilia Roh (South Pasadena, Calif.) and Robert G. Johnson Jr. (Lafayette, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions and methods for therapeutic delivery using an engineered viral vector. The engineered viral vector provided herein can improve therapeutic delivery, increase targeting efficiency, and decrease off-targeting or adverse effects."
The patent was filed on Nov. 14, 2024, under Application...